[-] Show simple item record

dc.contributor.authorWhaley-Connell, Adam T.eng
dc.contributor.authorHabibi, Javad, 1947-eng
dc.contributor.authorNistala, Ravieng
dc.contributor.authorCooper, Shawna A.eng
dc.contributor.authorKaruparthi, Poorna R.eng
dc.contributor.authorHayden, Melvineng
dc.contributor.authorDeMarco, Vincent G.eng
dc.contributor.authorAndresen, Bradley T.eng
dc.contributor.authorWei, Yongzhongeng
dc.contributor.authorFerrario, Carlos M.eng
dc.contributor.authorSowers, James R. (James Russell), 1942-eng
dc.date.issued2008eng
dc.description.abstractActivation of reduced nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase by angiotensin II is integral to the formation of oxidative stress in the vasculature and the kidney. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibition is associated with reductions of oxidative stress in the vasculature and kidney and associated decreases in albuminuria. Effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibition on oxidative stress in the kidney and filtration barrier integrity are poorly understood. To investigate, we used transgenic TG(mRen2)27(Ren2) rats, which harbor the mouse renin transgene and renin-angiotensin system activation, and an immortalized murine podocyte cell line. We treated young, male Ren2 and Sprague-Dawley rats with rosuvastatin (20 mg/kg IP) or placebo for 21 days. Compared with controls, we observed increases in systolic blood pressure, albuminuria, renal NADPH oxidase activity, and 3-nitrotryosine staining, with reductions in the rosuvastatin-treated Ren2. Structural changes on light and transmission electron microscopy, consistent with periarteriolar fibrosis and podocyte foot-process effacement, were attenuated with statin treatment. Nephrin expression was diminished in the Ren2 kidney and trended to normalize with statin treatment. Angiotensin II- dependent increases in podocyte NADPH oxidase activity and subunit expression (NOX2, NOX4, Rac, and p22phox) and reactive oxygen species generation were decreased after in vitro statin treatment. These data support a role for increased NADPH oxidase activity and subunit expression with resultant reactive oxygen species formation in the kidney and podocyte. Furthermore, statin attenuation of NADPH oxidase activation and reactive oxygen species formation in the kidney/podocyte seems to play roles in the abrogation of oxidative stress-induced filtration barrier injury and consequent albuminuria.eng
dc.identifier.citationAttenuation of NADPH Oxidase Activation and Glomerular Filtration Barrier Remodeling With Statin Treatment. Hypertension, 51, 474-480.eng
dc.identifier.issn1524-4563eng
dc.identifier.urihttp://hdl.handle.net/10355/8495eng
dc.publisherAmerican Heart Association, Inc.eng
dc.relation.ispartofNephrology publications (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Internal Medicine. Division of Nephrologyeng
dc.source.harvestedAmerican Heart Association web siteeng
dc.subjectprogressive glomerular dysfunctioneng
dc.subjectRASeng
dc.subjectendothelial dysfunctioneng
dc.subject.lcshStatins (Cardiovascular agents)eng
dc.subject.lcshOxidative stresseng
dc.subject.lcshHydroxymethylglutaryl coenzyme A reductaseseng
dc.titleAttenuation of NADPH Oxidase Activation and Glomerular Filtration Barrier Remodeling With Statin Treatmenteng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

  • Nephrology publications (MU)
    The items in this collection are the scholarly output of the faculty, staff, and students of the Division of Nephrology.

[-] Show simple item record